H

    Hyperion DeFi, Inc. (HYPD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.42
    +0.16 (+4.91%)

    Market Cap: $53.15M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(19/33)
    Avg Surprise
    -542.54%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.33
    Range$-1.02 - $0.36
    2 analysts
    EPS RevisionsNo revisions (7d)
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-2.84-760.6%
    60d ago$-0.03+90.9%
    30d ago$-0.04+89.4%
    7d ago$-0.04+89.4%
    Current$-0.33
    Revenue Consensus
    $550000
    Range$500000 - $600000
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.33
    Range$1.76 - $2.90
    2 analysts
    Revenue Consensus
    $-665500
    Range$-700000 - $-631000
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.33---
    Sep 26EST
    		-$-0.33---
    Jun 26
    Reported Aug 12
    		$0.92N/A-58.93%Miss+136.8%
    Mar 26
    Reported May 14
    		$0.26N/AN/ABeat+116.0%
    Dec 25
    Reported Mar 26
    		$-6.29$-4.62-36.15%Miss+61.7%
    Sep 25
    Reported Nov 13
    		$0.05N/A+100.78%Beat+100.6%
    Jun 25
    Reported Aug 13
    		$-2.50N/A+65.31%Beat+82.4%
    Mar 25
    Reported May 19
    		$-1.59N/A+80.13%Beat+89.6%
    Dec 24
    Reported Mar 26
    		$-16.44$-0.09-18166.67%Miss-9033.3%
    Sep 24
    Reported Nov 12
    		$-8.80$-8.00-10.00%Miss+38.9%
    Jun 24
    Reported Aug 13
    		$-14.20$-16.00+11.25%Beat-10.9%
    Mar 24
    Reported May 15
    		$-15.31$-13.87-10.38%Miss-10106.7%
    Dec 23
    Reported Mar 18
    		$-0.18$-0.17-5.88%Miss+98.7%
    Sep 23
    Reported Nov 13
    		$-14.40$-15.20+5.26%Beat+14.3%
    Jun 23
    Reported Aug 10
    		$-12.80$-16.00+20.00%Beat+27.3%
    Mar 23
    Reported May 11
    		$-0.15$-0.18+16.67%Beat+37.5%
    Dec 22
    Reported Mar 30
    		$-13.60$-16.80+19.05%Beat-270.0%
    Sep 22
    Reported Nov 10
    		$-16.80$-16.00-5.00%Miss+9.3%
    Jun 22
    Reported Aug 10
    		$-17.60$-17.60+0.00%Beat-15.8%
    Mar 22
    Reported May 12
    		$-0.24$-0.24+0.00%Beat+98.6%
    Dec 21
    Reported Mar 28
    		$8.00$-16.00+150.00%Beat+4805.9%
    Sep 21
    Reported Nov 10
    		$-18.52$-18.00-2.89%Miss-0.7%
    Jun 21
    Reported Aug 11
    		$-15.20$-19.20+20.83%Beat+24.0%
    Mar 21
    Reported May 12
    		$-16.80$-17.20+2.33%Beat+32.3%
    Dec 20
    Reported Mar 25
    		$-0.17$-0.17+0.00%Beat+45.2%
    Sep 20
    Reported Nov 10
    		$-18.40$-11.20-64.29%Miss+20.7%
    Jun 20
    Reported Aug 12
    		$-20.00$-16.80-19.05%Miss+43.2%
    Mar 20
    Reported May 13
    		$-24.80$-24.00-3.33%Miss-4860.0%
    Dec 19
    Reported Mar 25
    		$-0.31$-0.31+0.00%Beat+99.4%
    Sep 19
    Reported Nov 13
    		$-23.20$-28.27+17.93%Beat+32.6%
    Jun 19
    Reported Aug 12
    		$-35.20$-37.87+7.05%Beat-33.3%
    Mar 19
    Reported May 14
    		$-0.50$-0.51+1.96%Beat+98.6%
    Dec 18
    Reported Mar 27
    		$-48.00$-34.93-37.42%Miss-
    Sep 18
    Reported Nov 13
    		$-34.40$-33.60-2.38%Miss-
    Jun 18
    Reported Aug 14
    		$-26.40$-31.20+15.38%Beat-
    Mar 18
    Reported May 9
    		$-36.00$-31.20-15.38%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.68EV/EBITDA7.33x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin474.90%Operating Margin-758.00%
    ROE9.55%ROIC5.02%
    Financial Health
    Debt/Equity0.08xInterest Coverage7.04x
    Current Ratio2.34xQuick Ratio2.34x
    Trading Statistics
    Beta2.50Avg Volume519.10K
    52-Week High$15.0052-Week Low$2.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.24
    SMA 20$2.98
    SMA 50$2.95
    SMA 200$3.45
    EMA 10$3.25
    EMA 20$3.09
    EMA 50$3.03
    EMA 200$3.65

    MACD

    Line: 0.17Signal: 0.10Hist: 0.07

    ADX

    ADX: 29.1+DI: 31.1-DI: 12.9

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down8.0
    PSAR$3.09

    Bollinger Bands

    Upper Band$3.63
    Lower Band$2.33
    %B Position4363%(Upper)
    Band Width0.84

    RSI (14-Day)

    Neutral
    61.2

    Momentum Oscillators

    Stoch %K68.1
    Stoch %D74.7
    Williams %R-34.2
    ROC (10d)20.4%
    Momentum0.58
    CCI (20d)81.8
    MFI (14d)77.5

    Volatility Measures

    ATR (14d)$0.28(8.1%)
    StdDev (20d)0.33
    Hist Vol76.8%(High)

    Volume Flow

    VWAP$3.35
    OBV195.5M
    AD Line33.9M
    CMF (20d)-0.089

    Volume Metrics

    Avg Vol (20d)526.6K
    Vol Ratio0.8x
    VWMA (20d)$3.18

    Pivot Points

    R3$4.01
    R2$3.85
    R1$3.56
    Pivot Point$3.40
    S1$3.10
    S2$2.94
    S3$2.65

    Advanced Oscillators

    TSI20.91
    Ultimate Osc41.0
    KST156.26

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$357,693$244,271$496,229$302,506$0$14,720$28,093$1,625$22,625$4,993$2,589$1,198
    Cost of Revenue$0$0$303,242$0$0$48$3.10M$132,522$490,361$203,027$2,589$13,416
    Gross Profit$357,693$244,271$192,987$302,506$0$14,672$-3,073,225$-130,897$-467,736$-198,034N/A$-12,218
    Operating Expenses$-30,650,049$-8,487,848$39.96M$-4,125,685$8.35M$3.05M$16.38M$7.20M$11.22M$10.07M$7.47M$6.51M
    R&D$58,491$286,764$188,954$373,855$674,578$673,043$1.96M$3.47M$4.60M$4.43M$4.06M$3.58M
    SG&A$3.92M$4.49M$4.53M$2.59M$7.68M$2.37M$3.21M$3.73M$3.76M$3.64M$3.40M$2.93M
    Operating Income$31.01M$8.73M$-39,765,277$4.43M$-8,353,282$-3,030,693$-19,451,130$-7,331,927$-11,688,344$-10,266,824$-7,466,554$-6,520,186
    Interest Income$206,764$244,167$138,878$43,858$21,933$35,349$23,220$44,999$64,866$120,939$198,668$208,901
    Interest Expense$233,760$225,869$314,422$223,080$528,410$581,499$529,663$602,109$674,001$678,658$680,623$679,222
    Income Before Tax$30.95M$8.84M$-39,765,565$6.63M$-8,690,919$-3,483,533$-19,954,780$-7,887,853$-11,053,699$-10,922,101$-7,967,137$-7,338,733
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$30.95M$8.84M$-39,765,565$6.63M$-8,690,919$-3,483,533$-19,954,780$-7,887,853$-11,053,699$-10,922,101$-7,967,137$-7,338,733
    EBITDA$31.03M$8.88M$-39,574,993$6.71M$-7,876,906$-2,659,411$-18,944,064$-7,116,775$-9,707,242$-9,932,447$-7,023,452$-6,365,787
    EBIT$30.98M$8.82M$-39,590,021$6.80M$-8,184,442$-2,937,383$-19,448,337$-7,330,743$-10,444,564$-10,364,382$-7,485,182$-6,868,412
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about HYPD

    News

    Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program

    Eyenovia has announced the closing of a $50 million private placement and successfully accumulated over one million HYPE tokens. The company is now the first Nasdaq-listed entity to run a validator on Hyperliquid, with its token position acquired at an average price of approximately $34 per token. The announcement also provides an update on its Optejet development program.

    Barchart.com•8/28/26•
    Neutral

    FDA approves Eyenovia's ophthalmic spray for mydriasis

    The FDA has approved Eyenovia's MydCombi, an ophthalmic spray combining tropicamide and phenylephrine, for inducing mydriasis. This marks the first approved fixed-dose combination in the U.S. and the first product utilizing Eyenovia's Optejet device. MydCombi aims to improve the efficiency of eye exams and cataract surgery applications by delivering a micro-formulation that reduces systemic absorption and enhances patient comfort.

    Ophthalmology Times Europe•8/8/26•
    Bullish

    Eyenovia Inc (EYEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of Eyenovia Inc (EYEN), detailing its support, resistance, indicators, and moving averages. According to the analysis, EYEN's technical indicators show a "Buy" signal, with most moving averages indicating a buy. The company's stock is currently trading at $15.820.

    TradingKey•6/19/26•
    Neutral

    Eyenovia Inc (EYEN) Financial Health: Profitability & Balance Sheet Analysis

    This article provides a financial health analysis of Eyenovia Inc (EYEN), focusing on profitability and balance sheet aspects. It notes that relevant data for various financial metrics such as cash and cash equivalents, total assets, operating profit, and free cash flow have not been disclosed by the company yet. The stock closed at $15.820 on June 18, 2026, with a market cap of $44.78 million.

    TradingKey•6/18/26•
    Neutral

    Eyenovia Inc (EYEN) Institutional Confidence

    This article provides details on the institutional confidence score for Eyenovia Inc (EYEN), a company listed on Nasdaq, and lists several institutional shareholders. The data includes the number of shares held by each institution and the percentage change in their holdings. Key institutional investors mentioned are Forsakringsaktiebolaget Skadinviska Enskilda, Jung (Hyunsu), and Avenue Capital Group.

    TradingKey•6/18/26•
    Neutral

    Frequently Asked Questions About HYPD

    Does HYPD pay dividends?
    Hyperion DeFi, Inc. (HYPD) does not currently pay a regular dividend.
    What is HYPD's market cap?
    Hyperion DeFi, Inc. (HYPD) has a market capitalization of $53.15M with a current stock price of $3.42.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In